PathwayMap: Molecular Pathway Association with Self-Normalizing Neural Networks
Explore this paper's citation graph
Summary
A deep self-normalizing neural network model for the prediction of molecular pathway association is described and its performance is evaluated, showing an AUC ranging from 0.69 to 0.91 on a set of compounds extracted from ChEMBL.
- Type
- article
- Published
- 2018-12-26
- Cited by
- 27
- References
- 40
- Access
- Open access
- OpenAlex
- https://openalex.org/W30586501
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:58629014
Keywords
Humanities, Art
References
- Pan Assay Interference Compounds (PAINS) and Other Promiscuous Compounds in Antifungal Research.
- Greedy function approximation: A gradient boosting machine.
- Dark chemical matter as a promising starting point for drug lead discovery.
- Can the pharmaceutical industry reduce attrition rates?
- Metabolic Pathway Predictions for Metabolomics: A Molecular Structure Matching Approach
- Predicting Biological Functions of Compounds Based on Chemical-Chemical Interactions
- SMPDB 2.0: Big Improvements to the Small Molecule Pathway Database
- Anilinodialkoxyquinazolines: screening epidermal growth factor receptor tyrosine kinase inhibitors for potential tumor imaging probes.
- The Reactome pathway Knowledgebase
- Current Challenges and Trends in the Discovery of Agrochemicals
- Leave-Cluster-Out Cross-Validation Is Appropriate for Scoring Functions Derived from Diverse Protein Data Sets
- Clinical development success rates for investigational drugs
- Classifier chains for multi-label classification
- Mapping Human Metabolic Pathways in the Small Molecule Chemical Space
- Time-Split Cross-Validation as a Method for Estimating the Goodness of Prospective Prediction
- Comparison of human cell signaling pathway databases—evolution, drawbacks and challenges
- Predicting Metabolic Pathways of Small Molecules and Enzymes Based on Interaction Information of Chemicals and Proteins
- Deep learning in neural networks: An overview
- ChEMBL: a large-scale bioactivity database for drug discovery
- Prediction of small molecules' metabolic pathways based on functional group composition.
Cited by
- Machine Learning in Drug Discovery
- Design of drug-like hepsin inhibitors against prostate cancer and kidney stones
- Joint Virtual Special Issue on Computational Toxicology
- A Deep-Learning Approach toward Rational Molecular Docking Protocol Selection
- Drug discovery with explainable artificial intelligence
- Toxicity prediction based on artificial intelligence: A multidisciplinary overview
- Marine phycocompound screening reveals a potential source of novel senotherapeutics
- Coloring Molecules with Explainable Artificial Intelligence for Preclinical Relevance Assessment
- In silico insights into potential gut microbial modulation of NAD+ metabolism and longevity
- Computer-Aided Design and Synthesis of a New Class of PEX14 Inhibitors: Substituted 2, 3, 4, 5-Tetrahydrobenzo[F][1, 4]oxazepines as Potential New Trypanocidal Agents
- Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents
- Complex machine learning model needs complex testing: Examining predictability of molecular binding affinity by a graph neural network
- Pharmacophore screening, denovo designing, retrosynthetic analysis, and combinatorial synthesis of a novel lead VTRA1.1 against RecA protein of Acinetobacter baumannii
- Role of Artificial Neural Networks in Pharmaceutical Sciences
- Assessment of potassium ion channel during electric signalling in biofilm formation of Acinetobacter baumannii for finding antibiofilm molecule
- Anti-Inflammatory and Anti-Diabetic Activity of Ferruginan, a Natural Compound from Olea ferruginea
- Next Generation Radiotheranostics Promoting Precision Medicine.
- Artificial intelligence based virtual screening study for competitive and allosteric inhibitors of the SARS-CoV-2 main protease
- Model organism life extending therapeutics modulate diverse nodes in the drug-gene-microbe tripartite human longevity interactome
- Effect of the N501Y Mutation on Ligands Complexed with SARS-CoV-2 RBD: Insights on Potential Drug Candidates for COVID-19
Related papers
No related papers recorded.